AML3D (ASX:AL3) Expands Defence Manufacturing Footprint With Record Order Book

Aditi Sarkar

14 August 2026 04:25 PM AEST

AML3D (ASX:AL3) Expands Defence Manufacturing Footprint With Record Order Book

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

AML3D reported a record order book of $29 million at the end of FY2026.
The company received $10.4 million in cash receipts during FY2026, including $3.5 million in the June quarter.
ARCEMY systems are being deployed across US Navy shipbuilders and defence-related customers.
AML3D is expanding Manufacturing capacity through its US and European technology initiatives.

AML3D Ltd (ASX:AL3) is advancing its metal additive manufacturing strategy, with its ARCEMY systems and Wire Additive Manufacturing technology gaining adoption across the United States defence Supply chain. The company finished FY2026 with a record order book of $29 million, supported by ARCEMY system sales to US Navy shipbuilders and defence contractors.

At the time of writing on 14 August 2026, AML3D Ltd (ASX:AL3) was trading at AUD 0.097, down 3.00% on the day.

The company is focused on converting its growing defence customer base into a broader commercial manufacturing opportunity, while continuing Investment in production capacity and international expansion.

What Just Happened?

In its June 2026 quarterly update, AML3D reported a peak order book of $29 million at the end of FY2026, with $16.8 million of orders carrying into FY2027. Cash receipts for the full year reached $10.4 million, representing growth of approximately 20% YoY, including $3.5 million received during the June quarter.

During the quarter, AML3D commissioned approximately $6.8 million worth of ARCEMY systems. Four systems reached operational status, including a system valued at approximately $4.1 million for Newport News Shipbuilding, a portable system valued at around $1.1 million for an Austal USA and US Navy additive manufacturing centre, and a system valued at approximately $1.6 million for US defence supplier FasTech.

Newport News Shipbuilding had ordered a six-system ARCEMY fleet valued at $14.4 million, with two systems delivered by June 2026 and four additional systems scheduled for early 2027. AML3D also secured a $2.6 million contract earlier in the year to produce replacement components for the US Navy submarine fleet.

Why It Matters

The $29 million order book provides AML3D with contracted Revenue visibility and represents a transition from technology development toward commercial deployment. The $16.8 million order carryover into FY2027 provides a base of committed work as the company progresses into the new financial year.

Customer relationships within the defence sector are an important Factor for AML3D, with ARCEMY systems being adopted by organisations involved in naval manufacturing and defence supply chains. Qualification within these sectors can require extensive testing and compliance processes, making customer adoption a significant development milestone.

The company’s ability to convert these contracts into delivered systems and recurring customer relationships will determine the pace of future growth.

The Bigger Picture

AML3D, based in North Plympton, South Australia, specialises in metal additive manufacturing through its proprietary Wire Additive Manufacturing technology. The company’s ARCEMY systems use robotic manufacturing processes to produce large metal components for customers across defence and industrial markets.

The technology is designed to support production of complex or replacement metal parts while reducing reliance on traditional manufacturing methods such as forging and casting.

AML3D has focused on expanding its presence in the United States defence market, supported by investment in a Stow, Ohio Facility with approximately $12 million allocated toward capacity expansion. The company has also allocated around $5 million for a European technology centre targeting the United Kingdom and European markets.

As at 30 June 2026, AML3D estimated a global sales pipeline of approximately $78 million. The company has also strengthened its defence industry engagement through senior advisers with experience in US Navy operations and additive manufacturing.

What Could Drive the Shares Next?

Future ARCEMY system orders and conversion of the estimated $78 million sales pipeline into contracted revenue remain key milestones for AML3D. Additional orders from existing customers or new defence and industrial customers could further expand the company’s order book.

Delivery and commissioning of existing systems, including four Newport News machines scheduled for early 2027, will provide insight into the company’s ability to execute larger deployments.

Progress at the Stow, Ohio facility and development of the European technology centre could also influence future capacity and market expansion. Broader trends in defence manufacturing and supply chain localisation may continue to support Demand for additive manufacturing technologies.

Risks Investors Should Watch

AML3D faces risks associated with funding requirements, customer concentration, execution and competition. Expanding manufacturing capacity requires capital, and additional funding may be required as the company scales operations. A significant portion of demand is linked to US defence-related programmes, meaning changes in procurement priorities or defence spending could affect order flow. Delivery delays, commissioning challenges and technology qualification requirements may impact revenue timing. The company also operates in a competitive additive manufacturing sector and remains exposed to small-cap market volatility.

Bottom Line

AML3D Ltd (ASX:AL3) has progressed its Wire Additive Manufacturing technology into commercial applications, ending FY2026 with a record $29 million order book and $10.4 million in cash receipts. The company’s ARCEMY systems are being deployed across US Navy-linked customers and defence contractors, while investment in manufacturing capacity supports its expansion plans.

The next stage will depend on execution of existing contracts, conversion of the sales pipeline and management of funding requirements during expansion. Key areas for investors to monitor include order growth, system delivery timelines, customer concentration and the company’s ability to build sustainable operations.

FAQs

Q: What does AML3D do?

A:AML3D develops metal additive manufacturing technology, including its ARCEMY systems based on Wire Additive Manufacturing.

Q: What was AML3D’s FY2026 order book?

A:AML3D reported a record order book of $29 million at the end of FY2026.

Q: Who are AML3D’s key customers?

A:AML3D’s customers include US Navy shipbuilders and defence-related organisations using ARCEMY systems.

Q: What is the ARCEMY system?

A:ARCEMY is AML3D’s metal additive manufacturing system designed to produce large metal components.

Q: What are the main risks for AML3D?

A:Key risks include funding needs, customer concentration, execution challenges, competition and defence procurement changes.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.